322 related articles for article (PubMed ID: 21873682)
1. Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.
Huang H; Van de Veire S; Dalal M; Parlier R; Semba RD; Carmeliet P; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7565-73. PubMed ID: 21873682
[TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50/10 model.
Trichonas G; Lee TJ; Hoppe G; Au J; Sears JE
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4919-26. PubMed ID: 23761085
[TBL] [Abstract][Full Text] [Related]
3. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy.
Wang L; Shi P; Xu Z; Li J; Xie Y; Mitton K; Drenser K; Yan Q
Invest Ophthalmol Vis Sci; 2014 May; 55(7):4276-87. PubMed ID: 24867581
[TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy.
Sears JE; Hoppe G; Ebrahem Q; Anand-Apte B
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19898-903. PubMed ID: 19057008
[TBL] [Abstract][Full Text] [Related]
7. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
Sun M; Wadehra M; Casero D; Lin MC; Aguirre B; Parikh S; Matynia A; Gordon L; Chu A
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):3. PubMed ID: 32031575
[TBL] [Abstract][Full Text] [Related]
8. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
Pan X; Lv Y
Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
[TBL] [Abstract][Full Text] [Related]
9. TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.
Liang X; Zhou H; Ding Y; Li J; Yang C; Luo Y; Li S; Sun G; Liao X; Min W
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2157-69. PubMed ID: 22410554
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
11. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.
Zhao K; Jiang Y; Zhang J; Shi J; Zheng P; Yang C; Chen Y
Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424
[TBL] [Abstract][Full Text] [Related]
12. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
13. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
Saito Y; Uppal A; Byfield G; Budd S; Hartnett ME
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1591-8. PubMed ID: 18385079
[TBL] [Abstract][Full Text] [Related]
14. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N
Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.
Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.
Gardiner TA; Gibson DS; de Gooyer TE; de la Cruz VF; McDonald DM; Stitt AW
Am J Pathol; 2005 Feb; 166(2):637-44. PubMed ID: 15681845
[TBL] [Abstract][Full Text] [Related]
17. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685
[TBL] [Abstract][Full Text] [Related]
18. Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy.
Abdelsaid MA; Pillai BA; Matragoon S; Prakash R; Al-Shabrawey M; El-Remessy AB
J Pharmacol Exp Ther; 2010 Jan; 332(1):125-34. PubMed ID: 19815813
[TBL] [Abstract][Full Text] [Related]
19. Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model.
Yang L; Xu Y; Li W; Yang B; Yu S; Zhou H; Yang C; Xu F; Wang J; Gao Y; Huang Y; Lu L; Liang X
J Mol Neurosci; 2015 May; 56(1):78-88. PubMed ID: 25451596
[TBL] [Abstract][Full Text] [Related]
20. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
Brooks SE; Gu X; Samuel S; Marcus DM; Bartoli M; Huang PL; Caldwell RB
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):222-8. PubMed ID: 11133872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
